Which Banking ETF Is the Better Buy: iShares' European EUFN or Invesco's U.S.-Focused KBWB?

iShares MSCI Europe Financials ETF (EUFN) is framed as the more attractive buy versus Invesco KBW Bank ETF (KBWB), offering a higher trailing dividend yield of 3.9% vs 1.9% despite a higher 0.49% expense ratio (vs 0.35%). Over 5 years, EUFN shows a materially lower maximum drawdown (-35.2% vs -49.3%), and it has returned 31.1% over the past year vs KBWB’s 37.8% (as of 2026-08-10). The article attributes relative outperformance to European banks’ cheaper valuations and improving profit margins as interest-rate conditions became more favorable in Europe.

Analysis

This is more a relative-factor trade than a clean sector bet. EUFN is effectively a lower-beta, higher-carry basket with material insurer exposure, which tends to work when rates fall gradually and volatility stays muted; KBWB is the purer lever to U.S. deal activity, trading revenues, and operating leverage at money-center banks. That makes KBWB’s upside more cyclical and easier to disappoint if the M&A/IPO tape cools.

Second-order, the European sleeve has a built-in beneficiary in insurers such as ALIZY: lower rate volatility and better reinvestment conditions can support book value compounding even if bank NII is only okay. By contrast, KBWB’s concentration means a few names drive most of the outcome, so any stumble in CRE, mortgage, or capital-markets fees can hit the ETF harder than the headline diversification suggests.

The contrarian miss is that EUFN’s higher yield is not automatically “safer” income; it can be more policy-sensitive and more vulnerable to a growth scare or sovereign spread widening. The key falsifier for a long-EUFN/short-KBWB stance is a renewed acceleration in U.S. capital-markets revenue over the next 1-3 months, or a widening in European credit stress that forces the market to reprice payouts and liquidity premiums.

Key Decisions for Investors

• Initiate a 3-6 month relative-value pair: long EUFN / short KBWB, targeting 8-12% relative outperformance if U.S. fee income normalizes while European financials continue to rerate; stop if KBWB outperforms by ~5% or if U.S. bank guidance turns meaningfully higher.
• For income exposure, favor EUFN on pullbacks of 2-3% rather than chasing strength; the better entry is when rate-cut expectations reprice lower and the dividend screen becomes more compelling.
• Overweight ALIZY and HSBC within European financials versus U.S. bank proxies (JPM/BAC) for a slower-growth, lower-volatility tape; the risk/reward is better if the market starts paying for balance-sheet durability rather than fee-cycle momentum.
• Watch for a 1-3 month catalyst check: ECB/Fed divergence, U.S. M&A commentary, and European credit spreads. If U.S. capital-markets activity remains hot, cover the KBWB short first; if European sovereign spreads widen, reduce EUFN immediately.